CAFFEINATED COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES
申请人:Proteo Tech Inc
公开号:US20140194447A1
公开(公告)日:2014-07-10
Compounds and their pharmaceutically acceptable salts for treatment of β-amyloid diseases, such as observed in Alzheimer's disease and synucleinopathies, such as Parkinson's disease.
化合物及其药学上可接受的盐,用于治疗β-淀粉样蛋白病,例如阿尔茨海默病和突触核蛋白病,例如帕金森病。